Moderate

Toxoplasmosis (acute & in pregnancy)

Toxo · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Toxoplasma gondii causes mild/self-limited illness in the immunocompetent but serious disease in pregnancy (congenital infection), immunosuppression (encephalitis) and the eye (chorioretinitis). Management targets prevention of fetal transmission and tissue damage.

Red flags

  • Maternal seroconversion in pregnancy
  • Sight-threatening macular/optic nerve chorioretinitis
  • Focal neurological deficit in immunosuppressed
  • Severe disseminated disease
  • Neonatal signs of congenital infection

Assessment

Differential diagnosis

  • Infectious mononucleosis / other causes of lymphadenopathy
  • Lymphoma
  • Cerebral lymphoma (in HIV cerebral toxoplasmosis)
  • Other congenital infections (CMV, rubella)
  • Other causes of chorioretinitis

Investigations

  • Toxoplasma IgG and IgM (with avidity testing in pregnancy)
  • PCR of amniotic fluid for suspected congenital infection
  • MRI brain (ring-enhancing lesions) in immunosuppressed
  • Ophthalmological assessment for ocular disease
  • HIV test / immune status
  • Fetal ultrasound surveillance in maternal infection

Management

  • Confirm acute versus past infection with serology and IgG avidity
  • In immunocompetent adults with lymphadenopathy, usually reassure (self-limiting)
  • In pregnancy, assess timing of maternal infection and transmission risk
  • Start spiramycin to reduce vertical transmission while awaiting fetal testing
  • Perform amniocentesis PCR to confirm fetal infection
  • Switch to pyrimethamine-sulfadiazine-folinic acid if fetal infection confirmed (after first trimester)
  • Treat ocular disease threatening vision with anti-toxoplasma therapy +/- steroids
  • For cerebral toxoplasmosis in HIV, treat and optimise ART (covered separately)
  • Arrange paediatric/neonatal follow-up for exposed infants
  • Counsel on prevention (food hygiene, cat litter precautions)
  • Monitor for drug toxicity (marrow suppression - give folinic acid)
  • Long-term ophthalmology follow-up for ocular disease

Drugs & doses

Spiramycin 1 g PO three times daily (to prevent vertical transmission, maternal infection)
Pyrimethamine 50 mg PO daily + sulfadiazine 1 g PO four times daily + folinic acid 10-20 mg daily (confirmed fetal/active disease)
Pyrimethamine + sulfadiazine + folinic acid for ocular toxoplasmosis (plus corticosteroid if sight-threatening)
Co-trimoxazole as an alternative regimen in some settings

Disposition

Outpatient obstetric/ID or ophthalmology; fetal medicine referral in pregnancy; neonatal follow-up.

Complications & pitfalls

  • Congenital toxoplasmosis (chorioretinitis, intracranial calcification, hydrocephalus)
  • Vision loss from chorioretinitis
  • Cerebral toxoplasmosis in immunosuppression
  • Drug-induced marrow suppression
  • Reactivation with immunosuppression

Exam pearls

  • Spiramycin reduces transmission but does not treat established fetal infection
  • IgG avidity helps date infection relative to conception
  • Always co-prescribe folinic acid with pyrimethamine to protect the marrow
  • Most immunocompetent infections need no treatment
  • Prevention counselling (undercooked meat, cat litter) is key in pregnancy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.